Propranolol
M&A
STATUS
Buyout/LBO
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Provider of pharmaceutical products. The company provides generic propranolol hydrochloride extended release capsules used to treat hypertension.
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-backed
Primary Office
- 909 Third Avenue
- New York, NY 10022
- United States
Propranolol Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Propranolol‘s full profile, request access.
Request full access to PitchBookPropranolol Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Propranolol‘s full profile, request access.
Request full access to PitchBook